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Transcriptional control of KCNQ channel genes and the regulation of neuronal
excitability
Abstract
Regulation of the resting membrane potential and the repolarization of neurons are important in
regulating neuronal excitability. The potassium channel subunits Kv7.2 and Kv7.3 play a key role in
stabilizing neuronal activity. Mutations in KCNQ2 and KCNQ3, the genes encoding Kv7.2 and Kv7.3, cause
a neonatal form of epilepsy, and activators of these channels have been identified as novel antiepileptics
and analgesics. Despite the observations that regulation of these subunits has profound effects on
neuronal function, almost nothing is known about the mechanisms responsible for controlling appropriate
expression levels. Here we identify two mechanisms responsible for regulating KCNQ2 and KCNQ3 mRNA
levels. We show that the transcription factor Sp1 activates expression of both KCNQ2 and KCNQ3,
whereas the transcriptional repressor REST (repressor element 1-silencing transcription factor) represses
expression of both of these genes. Furthermore, we show that transcriptional regulation of KCNQ genes is
mirrored by the correlated changes in M-current density and excitability of native sensory neurons. We
propose that these mechanisms are important in the control of excitability of neurons and may have
implications in seizure activity and pain.

Keywords
control, kcnq, genes, transcriptional, regulation, channel, excitability, neuronal, CMMB

Disciplines
Life Sciences | Physical Sciences and Mathematics | Social and Behavioral Sciences

Publication Details
Mucha, M., Ooi, L., Linley, J., Mordaka, P., Dalle, C., Robertson, B., Gamper, N. & Wood, I. C. (2010).
Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. The Journal of
Neuroscience, 30 (40), 13235-13245.

Authors
Mariusz Mucha, Lezanne Ooi, John Linley, Pawel Mordaka, Carine Dalle, Brian Robertson, Nikita Gamper,
and Ian C. Wood

This journal article is available at Research Online: https://ro.uow.edu.au/scipapers/4659

The Journal of Neuroscience, October 6, 2010 • 30(40):13235–13245 • 13235

Cellular/Molecular

Transcriptional Control of KCNQ Channel Genes and the
Regulation of Neuronal Excitability
Mariusz Mucha, Lezanne Ooi, John E. Linley, Pawel Mordaka, Carine Dalle, Brian Robertson, Nikita Gamper,
and Ian C. Wood
Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, United Kingdom

Regulation of the resting membrane potential and the repolarization of neurons are important in regulating neuronal excitability. The
potassium channel subunits Kv7.2 and Kv7.3 play a key role in stabilizing neuronal activity. Mutations in KCNQ2 and KCNQ3, the genes
encoding Kv7.2 and Kv7.3, cause a neonatal form of epilepsy, and activators of these channels have been identified as novel antiepileptics
and analgesics. Despite the observations that regulation of these subunits has profound effects on neuronal function, almost nothing is
known about the mechanisms responsible for controlling appropriate expression levels. Here we identify two mechanisms responsible
for regulating KCNQ2 and KCNQ3 mRNA levels. We show that the transcription factor Sp1 activates expression of both KCNQ2 and
KCNQ3, whereas the transcriptional repressor REST (repressor element 1-silencing transcription factor) represses expression of both of
these genes. Furthermore, we show that transcriptional regulation of KCNQ genes is mirrored by the correlated changes in M-current
density and excitability of native sensory neurons. We propose that these mechanisms are important in the control of excitability of
neurons and may have implications in seizure activity and pain.

Introduction
Regulation of the resting membrane potential and the repolarization of neurons are important in regulating neuronal excitability.
One ionic current that plays a key role in stabilizing neuronal
activity is the M-current (IM), a slowly deactivating, noninactivating potassium current first identified nearly 30 years ago
as the one underlying the excitatory effect of acetylcholine
(Brown and Adams, 1980). The M-current is produced by the
action of Kv7 channels encoded by members of the KCNQ gene
family KCNQ1–KCNQ5, each of which encodes an individual
potassium channel subunit Kv7.1–Kv7.5 (Jentsch, 2000;
Robbins, 2001).
Of the five KCNQ gene family members, KCNQ2 and KCNQ3
are particularly important for regulating neuronal activity because these subunits are expressed widely throughout the CNS
with expression patterns that almost entirely overlap (Tinel et al.,
1998; Yang et al., 1998). Kv7.2 and Kv7.3 form functional heteromultimers that are believed to represent a major M-channel isoform in the CNS and peripheral nervous system (Delmas and
Brown, 2005). The importance of the appropriate functioning of
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Kv7.2 and Kv7.3 in the nervous system is highlighted by the fact
that mutations in KCNQ2 and KCNQ3 are associated with benign familial neonatal convulsions, an autosomal dominant neonatal epilepsy (Charlier et al., 1998; Singh et al., 1998; Yang et al.,
1998; Biervert and Steinlein, 1999). The M-current is also one
of the key players in nociceptive transmission; inhibition of
M-current leads to membrane depolarization and hyperexcitability of nociceptive neurons (Passmore et al., 2003; Crozier et
al., 2007; Linley et al., 2008; Liu et al., 2010), an important determinant of many pain conditions. Pharmacological openers of
Kv7.2/Kv7.3 channels therefore now represent important analgesic targets (Surti and Jan, 2005; Gribkoff, 2008; Wickenden and
McNaughton-Smith, 2009) because current therapies are not efficacious for the majority of inflammatory and chronic pain
conditions.
Despite their importance, very little is known about the mechanisms responsible for regulating KCNQ2 and KCNQ3 expression. Here we use a functional assay to identify important
regulatory regions within the KCNQ2 and KCNQ3 genes. We
show that both KCNQ2 and KCNQ3 contain GC box motifs and
provide evidence that their transcription is enhanced by the Sp1
transcription factor. We also show that expression of both
KCNQ2 and KCNQ3 is repressed by REST (repressor element
1-silencing transcription factor) and that expression of REST in
neurons is sufficient to repress KCNQ2 and KCNQ3 expression,
inhibiting functional expression of the M-current and resulting
in hyperexcitable neurons. We show that REST levels are increased in dorsal root ganglia (DRG) neurons in response to
inflammatory mediators and that Kv7.2 levels and M-current
density are reduced, suggesting a potential role in regulating inflammatory pain responses. Neuronal expression of REST is
increased in response to sustained neuronal hyperactivity, i.e., in

13236 • J. Neurosci., October 6, 2010 • 30(40):13235–13245

epileptic insults (Palm et al., 1998), cerebral ischemia (Calderone
et al., 2003), and a model of neuropathic pain (Uchida et al.); we
therefore suggest that, by repressing KCNQ2 and KCNQ3 expression, REST may contribute to chronic overexcitability of neuronal circuits seen in epilepsy and chronic pain.

Materials and Methods
Cell culture. SHSY-5Y and HEK293 cells were grown in DMEM/F-12
supplemented with 10% fetal calf serum (PAA Laboratories), 6 g/liter
penicillin, 10 g/liter streptomycin, and 2 mM L-glutamine at 37°C and 5%
CO2. DRG neurons were cultured as described previously (Crozier et al.,
2007; Linley et al., 2008; Liu et al., 2010); briefly, ganglia were extracted
from 7- to 10-d-old rats from all spinal levels. Ganglia were enzymatically
dissociated in HBSS supplemented with collagenase type 1A (1.5 mg/ml)
and dispase (15 mg/ml; Invitrogen) at 37°C for 15–20 min. Cells were
then mechanically triturated, washed twice by centrifugation (800 rpm
for 5 min), resuspended in 800 l of growth medium, and plated onto
glass coverslips coated with poly-D-lysine and laminin. DRG neurons
were cultured for 2–5 d in a humidified incubator (37°C, 5% CO2) in
DMEM supplemented with GlutaMAX I (Invitrogen), 10% fetal bovine
serum, penicillin (50 U/ml), and streptomycin (50 g/ml). For the inflammatory conditions, cells were incubated with the following inflammatory mediators for 48 h: 1 M bradykinin, 1 M histamine, 1 M ATP,
1 M substance P, and 10 M PAR-2 activating peptide. For patch-clamp
experiments, cells were washed twice and media were replaced with fresh
media that did not contain inflammatory mediators for at least 2 h before
experiments, to remove any acute effects of inflammatory mediators on
the M-current.
DNase I hypersensitivity assay. SHSY-5Y cells were washed twice with
ice-cold PBS, resuspended in DNase I buffer (10 mM Tris, pH 8.0, 50 mM
KCl, 5 mM MgCl2, 3 mM CaCl2, 1 mM DTT, 0.1% Nonidet P-40, and 8%
glycerol) and incubated on ice for 10 min. Cells were counted and transferred to a Dounce homogenizer and lysed with 15 strokes of a type B
pestle. Nuclei were divided into independent samples (⬃1.6 ⫻ 10 5 per
reaction) and treated with 0, 1, 3, 5, and 10 U of DNase I (Sigma) at 37°C
for 5 min. Reactions were stopped by addition of equal volume of stop/
lysis buffer (20 mM EDTA, 1% SDS, and 0.1 mg/ml proteinase K) and
incubated at 55°C overnight. DNA was extracted several times with phenol/chloroform and once with chloroform and then ethanol precipitated. DNA was resuspended in water, and the concentration was
measured by spectrophotometry. Ten micrograms of each sample were
digested overnight with the appropriate restriction enzymes in a final
volume of 30 l and electrophoresed through 40 mM Tris-acetate, 1 mM
EDTA, pH 8, and 0.6% (w/v) agarose gel at 0.5 V/cm. DNA was transferred to Hybond XL membranes (GE Healthcare) using alkaline capillary transfer. DNA fragments were radiolabeled using Prime-It kit
(Stratagene) and [␣- 32P]dATP. Hybridization to Hybond XL membranes was performed as per the instructions of the manufacturer.
Gel mobility shift assay. Nuclear extracts were prepared from SHSY-5Y
and JTC-19 cells using the method described previously (Andrews and
Faller, 1991). DNA probes were radioactively labeled by Klenow (New
England Biolabs) fill in of a restriction-enzyme-generated overhang using
[␣- 32P]dATP (GE Healthcare) and incubated with protein extracts before
electrophoresis through a 4% nondenaturing acrylamide gel. Specificity of
DNA–protein binding was assessed by including 10 pmol of doublestranded oligonucleotides, or 1 l of anti-Sp1 (2 mg/ml, H-255; Santa Cruz
Biotechnology) or 1 l of anti-REST (2 mg/ml, P-18; Santa Cruz Biotechnology) antibodies. Complimentary oligonucleotides with the following sequences were annealed and used for competition experiments: consensus
Sp1, 5⬘-GATCCCGATCGGGGCGGGGCG-3⬘; nonspecific, 5⬘-AATTCCCGCGAGGGGCGCCTAGTCCCCATG-3⬘; CHRM4 repressor element 1
(RE1), 5⬘-GTACGGAGCTGTCCGAGGTGCTGAATCTGCCT-3⬘; human
KCNQ2 RE1, 5⬘-GATCCTGGTCAGGACCATGGCCAGCACCCC; dog
KCNQ2 RE1, 5⬘-GATCTGCTGCTCAGGACCACGGCCAGCGCCTC;
mouse KCNQ2 RE1, 5⬘-GATCTTGAGTCCAGGACCATGGTCAGCACCAC; rat KCNQ2 RE1, 5⬘-GATCTTTGCGTCCAGGACCATGGTCAGCGCCAC; KCNQ1 RE1, 5⬘-GATCCGGGCCTGCACCCAGGACAGGGCC; KCNQ3 RE1, 5⬘-GATCAGGCTCAGGACCTAGGACAGT-
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TCC; KCNQ4, 5⬘-GATCCTGTCCAGGACCTGAGCCAGGGCT; and
KCNQ5 RE1, 5⬘-GATCCTTGTCAGCACCTAGGACAGAGAT.
Luciferase assay. Fragments of human KCNQ2 gene corresponding to
⫺64/⫹179 and ⫺416/⫹151 bp regions were amplified by PCR with the
following primers: Sp1 sense (s), 5⬘-AAAAGATCTCATGGTGCCTGGCGGGAGG; Sp1 antisense (a), 5⬘-AAGAGCTCAACGCGGGGCGGGGCGAG; AscIs, 5⬘-GGCGCGCCTCGGGCTCAGGCTCAG; and
AscIas, 5⬘-GGCGCGCCCTTGGTCCCTTCTGCC. Underlined nucleotides
correspond to newly formed restriction sites. Additionally, we introduced
mutations into the Sp1 binding site to prevent Sp1 binding using the primer
for Sp1s Mut, 5⬘- AAGAGCTCAACGCGGGGCAAGGCGAG, containing a
substitution of GG with AA (in bold). Amplified fragments were digested
with appropriate restriction enzymes and cloned into pGL3 Basic (Promega). Cells were transfected in 24-well plates with 250 ng of pGL3 plasmid
and 1 ng of pRL cytomegalovirus (Renilla luciferase; Promega) using 4 l of
Lipofectamine (Invitrogen). Each transfection was performed in triplicate
for each experiment. Cells were harvested 48 h after transfection into passive
lysis buffer, and luciferase and Renilla luciferase expression were quantified
using a Dual Luciferase Assay kit (Promega) on a Mediators PHL
luminometer.
Quantitative reverse transcriptase-PCR. Total RNA was extracted from
dorsal root ganglia cells using Tri-reagent (Sigma). DNase-treated (Ambion)
RNA was reverse transcribed by using Moloney murine leukemia virus reverse transcriptase (Promega) and purified using Qiaquick columns
(Qiagen). Quantitative PCR was performed using SYBR Green incorporation (Bio-Rad) for duplicate samples in each experiment. The specificity of
PCR was verified by melt curve analysis of products obtained from cDNA as
well as controls in which the reverse transcriptase was omitted. Levels of
signal were normalized to levels of U6 small nuclear RNA, which were not
different between any of the datasets. Significance was tested using Student’s
t test. Primers used were as follows: U6s, 5⬘-CTCGCTTCGGCAGCACA;
U6a, 5⬘-AACGCTTCACGAATTTGCGT; KCNQ2s, 5⬘-GTGGTCTACGCTCACAGCAA; KCNQ2a, 5⬘-AGGGTAAACGTCGCTGCTAA;
KCNQ3s, 5⬘-GCCCACAGTCCTGCCCATCTTGAC; KCNQ3a, 5⬘-CCGTTCCAGTTCCTCGTGGTTGACG; RESTs, 5⬘-CGAACTCACACAGGAGAACG; RESTa, 5⬘-GAGGCCACATAATTGCACTG; SCN2As,
5⬘-GCTGCATGTCTCTCTTGCTG; and SCN2Aa, 5⬘-GGACCGATTTGCTTCACTTC.
Western blot and immunocytochemistry. For Western blots, 10 g of
protein extracts from control and mithramycin A-treated SHSY-5Y cells
were electrophoresed through an SDS/10% (w/v) polyacrylamide gel using standard procedures, transferred to Hybond C-Extra (GE Healthcare), and screened with 1:1000 dilution of anti-Kv7.2 (Alomone Labs)
antibody and a 1:1000 dilution of horse radish peroxidase-conjugated
anti-rabbit antibody. Antibody staining was visualized using an ECL plus
detection kit (GE Healthcare). For immunocytochemistry, cells were
fixed and permeabilized in acetone/methanol 1:1 for 5 min on ice, followed by 0.1 M PBS/0.1% Triton X-100 for 5 min at room temperature
and blocked with 10% donkey serum in PBS for 2 h at room temperature.
Primary antibody incubation was performed in 10% donkey serum/0.4 M
PBS overnight at 4°C at 1:100 dilution for rabbit anti-REST (H290; Santa
Cruz Biotechnology), 1:1000 rabbit anti-Kv7.2 (kind gift from Dr. Mark
Shapiro, University of Texas Health Science Center at San Antonio, San
Antonio, TX) or 1:1000 guinea pig anti-TRPV1 (Neuromics), followed
by 1:1000 Alexa Fluor-555 donkey anti-rabbit or Alexa Fluor-488 donkey
anti-guinea pig secondary antibody (Invitrogen) in 0.1 M PBS for 2 h at
room temperature. Coverslips were mounted in Vectashield with 4⬘,6⬘diamidino-2-phenylindole (DAPI) and imaged using a Carl Zeiss LSM510
inverted confocal microscope. Among comparisons between cell conditions,
coverslips were mounted on the same slide and imaged with the same laser
settings. Image analysis was performed using NIH ImageJ software.
Plasmid and adenoviral delivery. The coding sequence for Sp1 was amplified using the primers 5⬘-GCGAATTCAATGAGCGACCAAGATCACTCA
and 5⬘-CGGAATTCTCAGAAACCATTGCCACTGAT and cloned into the
expression plasmid pTARGET (Promega). Freshly isolated DRG neurons
were transfected with pTARGET Sp1 or control plasmid using a Nucleofector device (Amaxa) and used 3–5 d after transfection. The green fluorescent
protein (GFP) plasmid pmaxGFP (Amaxa) was cotransfected as a marker of
the efficiency of transfection. The adenoviral constructs have been described
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previously (Wood et al., 2003). Green fluorescent protein was a marker of the
efficiency of viral infection. Cells were cultured and infected with adenoviral
particles for 48 h before harvesting and RNA or electrophysiological analysis.
Electrophysiology. In patch-clamp experiments, the standard bath solution contained the following (in mM): 160 NaCl, 2.5 KCl, 2 CaCl2, 1
MgCl2, and 10 HEPES, pH adjusted to 7.4 with NaOH. For perforatedpatch experiments, the patch pipette contained 90 mM K-acetate, 20 mM
KCl, 1 mM CaCl2, 3 mM MgCl2, 3 mM EGTA, 40 mM HEPES, and 400
g/ml amphotericin B, pH adjusted to 7.4 with NaOH. Currents were
amplified using an EPC-10 patch-clamp amplifier (HEKA) and recorded
using Patchmaster software (version 2.2; HEKA). The current signal was
sampled at 1 kHz and filtered online at 500 Hz using a software-based
Bessel filter. Patch pipettes were fabricated from borosilicate glass
(Harvard Apparatus) using a horizontal puller (DMZ-universal puller;
Zeitz-Instrumente GmbH) and heat polished to a resistance of 2– 4 M⍀.
Cells were mounted on an inverted microscope (TE-2000; Nikon) in a
low-profile perfusion chamber fed by a gravity perfusion system flowing
at ⬃2 ml/min, resulting in a bath exchange time of ⬃15 s. Series resistance was corrected online by up to 70% using the Patchmaster software,
and liquid junction potentials were corrected. The magnitude of the
neuronal M-current was measured from the deactivation current when
stepping the membrane voltage from ⫺30 to ⫺60 mV and was calculated
as the difference between current amplitude at 10 ms into the voltage
pulse and that at the end of the pulse. This analysis method was designed
to minimize any contribution from other K ⫹ currents and capacitance
artifacts. XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride] was obtained from Tocris Bioscience. All analysis of patchclamp data was conducted using Fitmaster software (version 2.11; HEKA).
Statistics. All data are given as mean ⫾ SEM. Differences between
groups were assessed by Student’s t test or one-way ANOVA. The differences were considered significant at p ⱕ 0.05.

Results
Identification of DNase I hypersensitive sites in the human
KCNQ2 gene
To identify regions of the KCNQ2 gene that are important for
regulation of expression in vivo, we used a DNase I hypersensitivity assay. DNase I hypersensitive sites (HSS) correlate well with
important transcriptional regulatory regions, such as promoters,
enhancer, and repressor elements (Fritton et al., 1987; Steiner et al.,
1987; Elgin, 1988; Wong et al., 1997), and map to regions that recruit
transcription factors (Wong et al., 1995; Boyes and Felsenfeld,
1996). A DNase I HSS assay was performed in SHSY-5Y cells,
which are known to express KCNQ2 and KCNQ3 (Wickenden et
al., 2008) and identified two HSS within the KCNQ2 gene (Fig.
1 A). We performed a bioinformatic analysis of the regions identified to look for transcription factor binding sites. An analysis of
HSS1 identified a putative Sp1 transcription factor binding site
(Fig. 1 B) that is conserved within the promoters of the human,
rat, and mouse KCNQ2 genes. It has been shown previously that
regions of DNA that recruit Sp1 display hypersensitivity to DNase
I (Philipsen et al., 1990; Pruzina et al., 1991; Jiang et al., 1997;
Sinha and Fuchs, 2001). An analysis of the region surrounding
HSS2 identified a putative binding site for the transcriptional
repressor REST that is conserved within multiple mammalian
species (Fig. 1C). REST binding to DNA is known to be sufficient
to produce a DNase I HSS (Wood et al., 2003).
KCNQ2 and KCNQ3 genes contain similar
regulatory elements
To determine whether the potential Sp1 factor binding sites are
important for KCNQ2 gene regulation, we used an in vitro DNA–
protein interaction experiment to examine the recruitment of
Sp1. A radiolabeled fragment of the KCNQ2 promoter containing the Sp1 site was incubated with nuclear protein extracts from
SHSY-5Y cells. Incubation of this region of DNA with nuclear
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protein produced two slowly migrating bands (Fig. 1 D, lane 1,
Sp1:DNA, Non spec) that could be competed by excess of an
unlabeled Sp1 consensus sequence (Fig. 1 D, lane 2). The faster
migrating DNA–protein complex could also be competed by an
unrelated sequence (Fig. 1 D, lane 3), indicating that this complex
is the result of nonspecific protein–DNA interactions. The slower
migrating protein–DNA complex could only be competed with a
consensus Sp1 sequence and was further retarded by an anti-Sp1
antibody (Fig. 1 D, lane 4, Sp1:Ab:DNA), indicating the presence
of Sp1 protein within this complex. Binding of the radiolabeled
probe was also competed by an excess of unlabeled wild-type Sp1
sequence from the KCNQ2 promoter (Sp1 WT) (Fig. 1 D, lanes 5,
6) but not by a KCNQ2 sequence containing mutations predicted
to destroy the Sp1 site (Sp1 mut) (Fig. 1 D, lanes 7, 8). These data
indicate that the Sp1 site within the KCNQ2 promoter can recruit
Sp1 protein present in SHSY-5Y cells. Given the overlap of
KCNQ2 and KCNQ3 expression and their shared evolutionary
origin by duplication from a common ancestor gene (Hill et al.,
2008), it is quite likely that these two genes would share at least
some regulatory mechanisms. We therefore searched the KCNQ3
gene for potential Sp1 and RE1 sites. We identified a conserved
Sp1 site in the KCNQ3 gene just upstream of the first exon, at an
equivalent location to the Sp1 site in the KCNQ2 gene (Fig.
1 E, F ). We also identified an RE1 site in the KCNQ3 gene that is
conserved across multiple mammalian species (Fig. 1 E, G). Thus,
the two regulatory elements that we identified within the KCNQ2
gene are also present in the KCNQ3 gene.
Sp1 regulates KCNQ2 and KCNQ3 expression
To determine whether the Sp1 site is functionally important in
regulating KCNQ2 and KCNQ3 transcription, we used a reporter
gene assay with the KCNQ promoter regions. We cloned a region
of the KCNQ2 promoter encompassing nucleotides ⫺416/⫹151
bp relative to the transcription start site into a luciferase reporter
vector such that luciferase expression is driven by KCNQ2 promoter sequences. This 568 bp region encompasses the Sp1 site
and 137 bp of the first exon. We also produced a truncated region
that lacks some of the sequence upstream of the Sp1 site (⫺64/
⫹179), and we introduced mutations into the Sp1 site that prevent Sp1 binding (⫺64/⫹179 Sp1 mut) (Fig. 1 D, lanes 7, 8). We
transfected these DNA constructs into SHSY-5Y cells and measured the resulting luciferase activity. Luciferase activity from the
⫺416/⫹151 bp promoter fragment was sixfold higher than the
control plasmid (Fig. 2 A, compare ⫺416/⫹151 bp with pGL3
Basic), suggesting that this region of the KCNQ2 gene and the Sp1
site within it elevate expression of KCNQ2. Removal of the upstream region did not result in a significant loss of expression,
suggesting that this region is not important in regulating transcription in SHSY-5Y cells (Fig. 2 A, compare ⫺416/⫹151 with
⫺64/⫹179 bp). Introduction of mutations that prevent Sp1
binding (see Materials and Methods) (Fig. 1 D), however, resulted in loss of ⬎50% luciferase activity (Fig. 2 A, compare ⫺64/
⫹179 with ⫺64/⫹179 bp Sp1 mut), consistent with the hypothesis
that KCNQ2 expression is regulated by Sp1. In our bioinformatic
analysis, we noticed that the KCNQ2 gene contained a second Sp1
site that overlapped with the first although its score was less,
suggestive of a lower affinity for Sp1 (supplemental Fig S1 A,
available at www.jneurosci.org as supplemental material). In gel
mobility shift experiments, this second site did indeed bind to
Sp1, showing a lower affinity than our originally identified site
(supplemental Fig S1 B, available at www.jneurosci.org as supplemental material). This second Sp1 site is unlikely to be bound by
Sp1 in the wild-type promoter because the presence of Sp1 at the
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high-affinity site, which overlaps with the
low-affinity site, would presumably occlude it. Mutation of the high-affinity site,
however, would uncover this second site,
and the low level of promoter activity seen
for the construct ⫺64/⫹179 Sp1 mut is
likely to be attributable to low levels of Sp1
recruitment. To determine whether the
KCNQ3 gene could also be regulated by
Sp1, we conducted a bioinformatic search
of the human KCNQ3 promoter region.
We identified a sequence matching a consensus Sp1 site that was highly conserved
between the human, mouse, and rat genomes (Fig. 1 F). To determine whether
this potential Sp1 site is functional, we
cloned an 876 bp region of the human
KCNQ3 gene encompassing nucleotides
⫺540 to ⫹336 relative to the transcription
start site and including the Sp1 site into
the same luciferase reporter vector as for
the KCNQ2 promoter. We also cloned a
region of the promoter encompassing nucleotides ⫺169 to ⫹336 that lacks the
conserved Sp1 site. Luciferase activity
from the ⫺540/⫹336 promoter region
drove high levels of luciferase expression
in SHSY-5Y cells (Fig. 2 B), which was reduced by ⬃80% when the region containing the Sp1 sites was removed (Fig. 2 B).
Together, these data suggest that Sp1 can
regulate both KCNQ2 and KCNQ3 promoter activity.

Figure 1.

DNase I hypersensitive sites present in the KCNQ2 gene. A, Top shows a schematic representation of the 5⬘ of the

KCNQ2 gene. Filled boxes represent exons, and the transcription start site is marked by an arrow. The location of identified
Sp1 regulates the endogenous KCNQ2
regulatory elements (Sp1 and RE1) are shown as open boxes. Below shows two DNase I hypersensitivity assays. Nuclei were
and KCNQ3 genes
isolated from SHSY-5Y cells and analyzed for DNase I hypersensitive sites. DNA was digested with HindIII (top) or AseI (bottom), and
Having shown that Sp1 can be recruited to the Southern blot was hybridized with a KCNQ2-specific probe. The positions of the hypersensitive sites (HSS1 and HSS2) are
the KCNQ2 promoter in vitro and the Sp1 indicated on the diagram as is the position of the full-length DNA fragment (F). B, DNA sequence alignment of the Sp1 sequence
site within the promoter is important for identified in the HSS1 region of the human KCNQ2 gene with the equivalent regions of the mouse and rat KCNQ2 genes. The
driving reporter gene activity, we wanted consensus Sp1 sequence is shown above the alignment (r, A or G; s, C or G). C, DNA sequence alignment of the RE1 sequence
to test the relevance of Sp1 transcription identified in the HSS2 region of the human KCNQ2 gene with the equivalent regions of the chimp, rhesus, mouse, rat, dog, cow and
factor activity to endogenous KCNQ2 and elephant KCNQ2 genes. The consensus RE1 sequence is shown above the alignment (n, A, C, G, or T; y, C or T; m, A or C). D, Gel
SHSY-5Y cells
KCNQ3 expression. To do this, we took mobility shift assay of the Sp1 region of the KCNQ2 promoter. Labeled DNA was incubated with protein isolated from
con
advantage of mithramycin A, a com- in the presence of no competitor (No comp, lane 1), oligonucleotides containing a consensus Sp1 sequence (Sp1 , 1 M, lane 2),
(␣-Sp1, 1 g, lane 4), or oligonucleotides containing the
pound that binds to Sp1 binding sites (GC an unrelated sequence (Non spec, 1 M, lane 3), an anti-Sp1 antibody
wild-type or mutated Sp1 sequence from the KCNQ2 promoter (Sp1 wt: 1 M, lane 5; 10 M, lane 6; Sp1 mut: 1 M, lane 7; 10 M,
box) and inhibits the function of Sp1 (Ray lane 8). Position of complexes containing Sp1 (Sp1:DNA), ␣-Sp1 (Ab:Sp1:DNA), and resulting from nonspecific binding (Non spec)
et al., 1989; Liu et al., 2002; Kim et al., are shown on the left. E, A schematic representation of the 5⬘ of the KCNQ3 gene. Filled boxes represent exons, and the transcription
2006). Transfection of KCNQ2 and start site is marked by an arrow. The location of identified regulatory elements (Sp1 and RE1) are shown as open boxes. F, DNA
KCNQ3 luciferase reporter constructs sequence alignment of the Sp1 sequence identified in the human KCNQ3 gene with the equivalent regions of the mouse and rat
into SHSY-5Y cells in the presence of KCNQ3 genes. The consensus Sp1 sequence is shown above the alignment (r, A or G; s, C or G). G, DNA sequence alignment of the RE1
mithramycin A resulted in a 66 and 90% sequence identified in the human KCNQ3 gene with the equivalent regions of the chimp, rhesus, mouse, rat, dog, cow, and
reduction in luciferase activity, respec- elephant KCNQ2 genes. The consensus RE1 sequence is shown above the alignment (n, A, C, G, or T; y, C or T; m, A or C).
tively (Fig. 2C). To determine the role of
mycin A also resulted in a reduction of Kv7.2 protein (Fig. 2 E). As
Sp1 on endogenous gene expression, we incubated neurons isoan alternative approach to determine whether Sp1 was important
lated from DRG in the presence of 200 nM of mithramycin A for
in regulating expression of KCNQ2 and KCNQ3, we transfected
48 h and measured mRNA expression using quantitative PCR. In
DRG neurons with an Sp1 expression plasmid and measured
the presence of mithramycin A, KCNQ2 and KCNQ3 levels were
Kv7.2 expression and M-current densities. We transfected a plasreduced by 90% (Fig. 2 D), suggesting that Sp1 is critical for drivmid expressing GFP alongside either the Sp1-expressing or the
ing endogenous KCNQ2 and KCNQ3 expression. Expression of
control plasmid to identify transfected neurons (Fig. 3A). In
the SCN2A gene, which encodes the type II sodium channel, was
whole-cell voltage-clamp experiments, IM was measured from a
unaffected by mithramycin A, suggesting that the effect on
standard square voltage pulse protocol stepping to ⫺60 mV from
KCNQ expression was not the result of a global change in gene
a holding potential of ⫺30 mV (Fig. 3B, inset) as an amplitude of
expression (Fig. 2 D). Incubation of SHSY-5Y cells with mithra-
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sequence (Fig. 4 A, lanes 2, 3). Furthermore, an anti-REST antibody produced
an additional shift of this complex, indicating the presence of REST protein (Fig.
4 A, lane 4). Oligonucleotides containing
RE1 sequences from human, dog, mouse,
and rat were all able to compete for REST
binding, indicating that the KCNQ2 gene
contains an evolutionary conserved, functional RE1 site (Fig. 4 A, lanes 5–12).
To determine whether RE1 sites are
present in other KCNQ genes, we used our
position-specific scoring matrix (Johnson
et al., 2006) to scan each of the five KCNQ
genes for the best match to an RE1. Highscoring RE1s were identified in KCNQ2,
KCNQ3, and KCNQ5, whereas the closest
sequences in KCNQ1 and KCNQ4 to an
RE1 site had low scores with our matrix,
suggesting they would not bind REST. We
tested each of these potential RE1 sequences in a gel mobility shift assay to determine which would bind REST with
high affinity (Fig. 4 B). The RE1 sequences
from KCNQ2, KCNQ3, and KCNQ5 were
each able to compete for REST binding,
Figure 2. The KCNQ2 and KCNQ3 promoters contain functional Sp1 sequences. A, Regions of the KCNQ2 promoter were cloned whereas the sequences in KCNQ1 and
upstream of luciferase and transfected into SHSY-5Y cells. Shown are normalized luciferase values expressed relative to empty KCNQ4 could not (Fig. 4 B). To detervector, pGL3 Basic (mean ⫾ SEM; n ⫽ 3; *p ⬍ 0.05). Base pair numbers are expressed relative to transcription start sites. B, mine whether REST could regulate the
Regions of the KCNQ3 promoter were cloned upstream of luciferase and transfected into SHSY-5Y cells. Shown are normalized KCNQ2 and KCNQ3 promoters, we
luciferase values expressed relative to empty vector (mean ⫾ SEM; n ⫽ 3; *p ⬍ 0.05). C, Luciferase reporter vector containing the cloned the RE1 sequences upstream of the
KCNQ2 or KCNQ3 promoter regions or empty vector, pGL3 Basic (Basic), were transfected into SHSY-5Y cells that were subsequently
luciferase reporter constructs (Fig. 2 A)
treated with either 100 nM mithramycin A or water control. D, Reverse transcriptase-PCR analysis of KCNQ2, KCNQ3, and SCN2A
mRNA levels in control and mithramycin A-treated cultures of rat dorsal root ganglia cells. Levels are normalized to U6 gene and transfected them into two cell lines,
(mean ⫾ SEM; n ⫽ 3; *p ⬍ 0.05). E, Antibodies to Kv7.2 and ␤-actin were used to analyze respective protein levels in extracts HEK293, which express robust levels of
full-length REST natively, and SHSY-5Y,
from control or mithramycin A (Mith, 100 nM)-treated SHSY-5Y cells.
which express low levels of REST as well as
a truncated version of REST resulting
deactivating tail current at ⫺60 mV sensitive to specific M channel
from an alternative splice variant (our unpublished observablocker XE991 (3 M) applied at the end of each recording.
tions). Inclusion of the RE1 site resulted in robust repression of
M-current density was significantly larger in Sp1-transfected comluciferase activity for both KCNQ2 and KCNQ3 promoters in
pared with control neurons (Fig. 3B,C) (1.54 ⫾ 0.34 pA/pF, n ⫽ 8
HEK293 (Fig. 4C), indicating that recruitment of REST to the
compared with 0.91 ⫾ 0.12 pA/pF, p ⬍ 0.05). Consistently, the Kv7.2
RE1 site represses KCNQ2 and KCNQ3 expression. Consistent
immunoreactivity was greater in Sp1-transfected than in control neuwith the observation that SHSY-5Y cells express less REST prorons (Fig. 3A,D) (relative pixel intensity of 9.53 ⫾ 2.15, n ⫽ 4 compared
tein, inclusion of the RE1 site resulted in only modest repression
with 5.49 ⫾ 0.85, n ⫽ 3, p ⬍ 0.05). Together, these data implicate an
of luciferase activity for the KCNQ3 promoter in SHSY-5Y,
important role for Sp1 in promoting both KCNQ2 and KCNQ3 gene
whereas the KCNQ2 promoter did not show a significant reducexpression and enhancing levels of the M-current in neurons.
tion in activity (Fig. 4 D). REST is normally expressed in high
levels in non-neuronal cells and only at low levels in neurons (Sun
KCNQ genes are regulated by REST
et al., 2005; Olguín et al., 2006). Our luciferase data suggest that
Bioinformatic analysis of the second DNase I hypersensitive site
the absence or the low levels of REST in neurons may be impor(Fig. 1 A, HSS2) in the KCNQ2 gene identified a putative RE1
tant for permitting KCNQ2 and KCNQ3 expression. However,
binding site for REST. The sequence for this site is conserved
after
epileptic seizures, global ischemia, or neuropathic injury,
between multiple mammalian species (Fig. 1C), suggesting that it
conditions
characterized by periods of sustained neuronal hyperis functionally important. REST was first identified as a repressor
activity, REST expression was seen in neurons (Palm et al., 1998;
of neuronal gene expression (Chong et al., 1995; Schoenherr and
Calderone et al., 2003; Uchida et al., 2010). To determine whether
Anderson, 1995) but also has roles in heart, blood vessels, and
such increased REST expression in neurons may affect KCNQ2
epithelial cells (Ooi and Wood, 2007). We used a gel mobility
and KCNQ3 expression, we infected cultured DRG neurons with
shift assay to determine whether the RE1 site identified in the
either GFP alone (control) or REST and GFP-expressing adenoKCNQ2 gene can recruit REST protein. Incubation of a radioacvirus (Ad) particles. Infection of DRG neurons with control adtive, RE1-containing, SCN2A promoter region with nuclear exenovirus had no effect on KCNQ2 mRNA, whereas infection with
tracts resulted in DNA–protein complexes (Fig. 4 A, lane 1). One
adenovirus driving REST expression resulted in a significant reof these (indicated with an arrow on Fig. 4 A) was competed by an
RE1 sequence from the CHRM4 gene but not by an unrelated
duction of KCNQ2 and KCNQ3 mRNA (Fig. 4 E).
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Overexpression of REST reduces
M-current density and changes firing
properties of DRG neurons
KCNQ2 and KCNQ3 encode the two subunits Kv7.2 and Kv7.3, which together
form a heterotetrameric potassium channel that is believed to be the most abundant M-channel isoform in the CNS and
peripheral nervous system (Delmas and
Brown, 2005). IM is a slowly activating and
deactivating potassium current that provides a brake for repetitive action potential (AP) firing (Wang et al., 1998). To
determine whether increased neuronal
REST expression could downregulate
the endogenous M-current, we infected
cultured DRG neurons with RESTexpressing adenovirus and examined the
electrophysiological properties of these
neurons. DRG neurons significantly differ
in their function and channel expression
profile; thus, to restrict our study to a
more homogeneous population of neuFigure 3. Sp1 enhances Kv7.2 expression and M-current density. A, Fluorescent images of DRG neurons transfected with a
rons, we applied the TRPV1 agonist cap- GFP-expressing plasmid and an Sp1-expressing (top) or control (bottom) plasmid. Transfected cells were identified by GFP expressaicin (1 M) at the end of each recording sion (green). Kv7.2 levels were analyzed using an anti-Kv7.2 antibody and Alexa Fluor-555-conjugated secondary antibody (red).
and only considered those neurons that Nuclei are counterstained with DAPI (blue). Scale bars, 10 m. B, Whole cell voltage-clamp traces obtained by 500 ms voltage
were TRPV1 positive (nociceptive neu- pulses from ⫺30 to ⫺60 mV as indicated by the voltage pulse protocol (inset). Black trace represents steady state basal current;
rons). Whole-cell currents were measured red trace represents current in the presence of the specific M-channel blocker XE991 (3M). Dotted line indicates zero current. C,
from small (whole-cell capacitance of BarsshowpooledcurrentdensitydatadeterminedfromtheDRGneuronstransfectedwithanSp1-expressing(Sp1;n⫽8)orcontrol(Con;
23.7 ⫾ 2.8 pF, n ⫽ 28) DRG neurons us- n⫽7)plasmid.MagnitudeofM-currentwascalculatedastheXE991-sensitivedeactivationcurrentwhensteppingfrom⫺30to⫺60mV
ing a standard voltage protocol for and normalized to cell capacitance (IM density, mean ⫾ SEM; *p ⬍ 0.05). D, Bars show pixel intensity of Kv7.2 staining in DRG neurons
M-current (Fig. 5A, inset). In control cells transfected with Sp1-expressing (Sp1; n ⫽ 4) or control (Con; n ⫽ 3) plasmid (mean ⫾ SEM; *p ⬍ 0.05).
infected with adenoviral construct coding
mV by injection of current. Injection of ⫹400 pA produced one
for GFP alone, the hyperpolarizing test pulse resulted in a slowly
AP in the majority (seven of nine) of Ad-infected cells and two
deactivating whole-cell current, characteristic of M-current,
action potentials in the remainder (two of nine) of cells with a
which was sensitive to the specific M-channel blocker XE991 (3
similar pattern of firing observed in non-infected AdREST cells
M; 62 ⫾ 4% inhibition of deactivation current, n ⫽ 8). In neu(five of six cells firing one AP). In contrast in REST overexpressrons infected with AdREST, IM was dramatically reduced to 14%
ing cells, 6 of 11 cells fired multiple action potentials (mean AP
of the value of control Ad neurons ( p ⬍ 0.01, n ⫽ 9 for GFP and
number of 6.5), which did not show accommodation (Fig. 5B),
n ⫽ 11 for GFP ⫹ REST-expressing neurons) (Fig. 5C). We also
indicating that the brake on neuronal firing had been removed.
compared responses of virally infected neurons with 1 M of the
REST-overexpressing neurons also were significantly depolarTRPV1 agonist capsaicin (measured as the inward current at ⫺60
ized compared with controls (Fig. 5D: AdREST, ⫺60.5 ⫾ 2.4 mV;
mV). Capsaicin responses were unaltered by REST overexpresAd, ⫺67.6 ⫾ 2.6 mV; Non-infected, ⫺68.6 ⫾ 2.3 mV; n ⫽ 8;
sion (control, ⫺21.8 ⫾ 8.9 pA/pF, n ⫽ 9; REST, ⫺26.6 ⫾ 7.5
ANOVA, p ⬍ 0.01), consistent with a reduction in M-current in
pA/pF, n ⫽ 11; ANOVA, p ⫽ NS) (data not shown), suggesting
these cells. REST has many gene targets (Bruce et al., 2004; Johnthat the effect of REST was specific to its target genes. To further
son et al., 2009) in addition to the KCNQ genes, and the change in
confirm that viral infection did not affect IM nonspecifically,
the excitability profile of a DRG neuron after REST overexpression is
whole-cell currents were measured from non-infected neurons
likely to reflect multiple changes in the expression of ion channels at
from AdREST-exposed neuronal cultures. In these cells, IM was
the neuronal membrane. However, experimental data (Gamper et
not significantly different from Ad controls (2.21 ⫾ 0.26 vs
al., 2006) and modeling (Zaika et al., 2006) suggest that inhibition of
2.37 ⫾ 0.48 pA/pF, n ⫽ 8; p ⬍ 0.05) but was significantly larger
M-current alone is sufficient to explain the increase in DRG neuron
than REST-infected cells (0.31 ⫾ 0.10 pA/pF, n ⫽ 8; ANOVA, p ⬍
firing rate observed here. In additional support to this assumption,
0.01) (Fig. 5C). Thus, increasing REST expression (Fig. 5A, Adthe selective Kv7 blocker XE991 produced an increase in AP firing
REST) resulted in almost a complete absence of the M-current
when acutely applied to a nontransfected DRG neuron (Fig. 5E), the
when compared with uninfected neurons from the same dish
increase in excitability was similar to that produced by REST over[Fig. 5A, AdREST (non-infected)] or neurons infected with a
expression. These data suggest that the regulation of KCNQ gene
control adenovirus (Fig. 5A, Ad).
expression levels underlies the increased neuronal excitability resultM-current is known to contribute to the resting membrane
ing from expression of REST.
potential and acts as a brake on AP firing of DRG neurons (PassAlthough its levels are normally low, neuronal REST expresmore et al., 2003; Linley et al., 2008). We therefore tested whether
sion was shown to increase after extended periods of neuronal
increasing REST expression affected the AP firing properties and
overactivity seen in seizures, ischemia, and neuropathic pain
the resting membrane potential of DRG neurons. Using wholecell current clamp, the membrane potential was adjusted to ⫺65
(Palm et al., 1998; Calderone et al., 2003; Uchida et al., 2010).

Mucha et al. • KCNQ Gene Regulation

J. Neurosci., October 6, 2010 • 30(40):13235–13245 • 13241

before experiments to remove any acute
effects on IM. Inflammatory conditions
dramatically reduced IM compared with
control (0.25 ⫾ 0.04 compared with
0.95 ⫾ 0.16 pA/pF; p ⱕ 0.01; n ⫽ 9 for
control and n ⫽ 5 for inflammatory), consistent with a downregulation of KCNQ2
and KCNQ3. These data are consistent
with a mechanism whereby REST levels
are increased in nociceptive neurons in
response to inflammatory signals, resulting in an increase in excitability
brought about by the reduced expression of KCNQ2 and KCNQ3. Such a
mechanism could contribute to a longterm peripheral sensitization of inflamed sensory fibers.

Discussion
In this work, we have identified two common mechanisms that regulate expression
of KCNQ2 and KCNQ3. We have identified consensus sequences for the Sp1 transcription factor in each of the promoter
regions. These sequences are evolutionarFigure 4. The KCNQ2 and KCNQ3 promoters are regulated by the transcriptional repressor REST. A, B, Labeled DNA containing ily conserved, and we show that Sp1 dithe SCN2A RE1 site was incubated with nuclear protein in the presence of no competitor (No comp, lane 1), oligonucleotides rectly interacts with the KCNQ2 promoter
containing an RE1 site from the CHRM4 promoter (CHRM4, lane 2), an unrelated sequence (Non spec, lane 3), an anti-REST antibody
in vitro and that removal or mutation of
(␣-REST, lane 4), and oligonucleotides containing sequence from the human (lanes 5, 6), dog (lanes 7, 8), mouse (lanes 9, 10), and
these sequences results in reduced activity
rat (lanes 11, 12) KCNQ2 genes (A) or oligonucleotides containing potential RE1 sequences from the human KCNQ1–KCNQ5 genes
(lanes 5–14) (B). Concentration of competing oligonucleotides were 1 M (lanes 5, 7, 9, 11, 13) or 10 M (lanes 2, 3, 6, 8, 10, 12, of the promoters. Furthermore, chemical
14). Positions of REST–DNA and REST–DNA–antibody complexes are identified by arrows on the left. C, D, Luciferase activity driven inhibition of Sp1–DNA interactions refrom KCNQ2 and KCNQ3 promoters with or without the RE1 site, transfected into HEK293 cells (C) or SHSY-5Y cells (D). The arrows sult in reduced KCNQ2 and KCNQ3
on the KCNQ3 RE1 site represent the direction of the sequence. Expression levels were normalized for transfection efficiency with mRNA expression, whereas ectopic Sp1
Renilla luciferase and are expressed relative to empty plasmid, pGL3 basic (mean ⫾ SEM; n ⫽ 3; *p ⬍ 0.05). E, Reverse results in increased M-current and Kv7.2
transcriptase-PCR analysis of KCNQ2 and KCNQ3 mRNA levels in cultured rat dorsal root ganglia cells infected with control adeno- expression in cultured neurons. Our data
virus or adenovirus expressing full-length REST (⫹). Data are normalized to U6 gene and expressed relative to cells infected with implicating Sp1 as an important positivecontrol adenovirus (mean ⫾ SEM; n ⫽ 3; *p ⬍ 0.05).
acting transcription factor that regulates
KCNQ2 expression are consistent with a
previous report on the human KCNQ2
Having shown that REST can regulate the expression of KCNQ2
promoter (Xiao et al., 2001). Xiao et al. used a bioinformatic
and KCNQ3 in DRG neurons, we sought to determine whether
analysis to identify GC boxes in the proximal promoter of
REST levels in DRG neurons may be increased physiologically.
KCNQ2. Our new data show that these GC box regions are evoWe recently reported that inflammatory mediators increase the
lutionarily conserved and are also present in the KCNQ3 proexcitability of nociceptive DRG neurons via inhibition of the
moter. Furthermore, Sp1 does in fact interact with these GC
M-current mediated through short-term G-protein signaling
boxes, and this interaction is important for expression of the
events (Linley et al., 2008; Liu et al., 2010). Long-term changes in
endogenous KCNQ2 and KCNQ3 mRNA in neurons. The physnociceptive neurons have been proposed to be important in the
iological relevance of Sp1 regulation of KCNQ2 and KCNQ3 redevelopment of chronic pain (for review, see Basbaum et al.,
mains to be determined, and, although Sp1 is often thought of as
2009; Linley et al., 2010) and are likely to be the result of changes
a constitutive transcriptional activator, recent evidence suggests
in gene expression. We therefore cultured DRG neurons in the
that Sp1 activity is important for mediating changes in neuronal
presence of a mix of inflammatory mediators to mimic inflamgene expression in response to developmental or disease stimuli.
mation (1 M bradykinin, 1 M histamine, 1 M ATP, 1 M
For example, induced expression of the reelin gene during neusubstance P, and 10 M PAR-2 activating peptide) and analyzed
ronal differentiation is dependent on Sp1, and mutation in the
the expression of REST and Kv7.2 specifically in the nociceptive,
binding site for Sp1 within the reelin promoter is sufficient to
TRPV1-positive, neurons (Fig. 6 A–C). In control conditions,
prevent increased reelin expression (Chen et al., 2007). Sp1 is also
REST levels in nociceptive neurons were very low, but they inimportant for the increased expression of the damage-induced
creased significantly in response to inflammatory mediators (Fig.
neuronal endopeptidase (DINE) gene in response to nerve injury
6 A, C). The levels of TRPV1 in nociceptive neurons did not
(Kiryu-Seo et al., 2008). In this context, Sp1 acts as a platform to
change significantly (Fig. 6C) (TRPV1 is not a predicted target
which other transcription factors are recruited in response to
gene of REST). TRPV1-positive neurons cultured in inflammanerve injury and activate expression of DINE (Kiryu-Seo et al.,
tory conditions showed lower Kv7.2 immunoreactivity than
2008).
those in control conditions (Fig. 6 B, C). We also analyzed
Our data also highlight a second conserved mechanism for the
M-current density in capsaicin-responsive neurons. For patch
clamp, inflammatory mediators were washed out for at least 2 h
regulation of KCNQ2 and KCNQ3: repression by REST. Both
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KCNQ2 and KCNQ3 contain evolutionarily conserved REST binding sites that
can interact with REST in vitro, and overexpression of REST in neurons results in
reduced KCNQ2 and KCNQ3 mRNA and
loss of M-current. Interestingly, we also
identified a functional binding site for
REST in the KCNQ5 gene, suggesting that
KCNQ5 may also be repressed by REST.
Like KCNQ2 and KCNQ3, KCNQ5 is
widely expressed throughout the nervous
system, and it has been suggested that
Kv7.5 subunits may contribute to the
M-current in vivo either on their own or in
complex with Kv7.3 (Lerche et al., 2000;
Schroeder et al., 2000). In a whole genome
chromatin immunoprecipitation analysis
to look at REST binding in human Jurkat
cells, REST is enriched at the RE1 sites for
KCNQ2 and KCNQ3 (Johnson et al.,
2007). In that study, REST was not found
to be present at the KCNQ5 RE1 site we
identified, but this may be a cell-specific
effect because enrichment of REST at the
KCNQ5 RE1 site has been identified in
several other human cell lines (Bruce et
al., 2009). Although REST was originally
proposed to be important in silencing
neuronal-specific genes in non-neuronal
cells (Chong et al., 1995; Schoenherr and
Anderson, 1995), it clearly has a functional role within the nervous system.
REST is expressed at low levels in neurons
and regulates some target genes (Wood et
al., 2003). Neuronal REST expression is
upregulated in response to epileptic insults and cerebral ischemia resulting in
reduced expression of brain derived neurotrophic factor (BDNF) and the glutamate receptor subunit gene GRIA2 and
increased expression of the substance P
gene PPT-A (Palm et al., 1998; Calderone
et al., 2003; Garriga-Canut et al., 2006;
Spencer et al., 2006). In addition, nuclear
levels of REST protein are elevated in neurons in Huntington’s disease, leading to
reduced BDNF expression (Zuccato et al.,
2003, 2007).
Individuals who suffer an epileptic seizure become more susceptible to additional seizure activity (Hauser and Lee,
2002). The molecular mechanisms underlying this long-term change are not
known, although, like other features of
the brain that show long-lasting changes,
e.g., long-term potentiation, they most
likely involve changes in gene expression.
The expression of several transcription
factors has been shown to be increased in
response to seizure activity in rodents.
These include c-Fos (Morgan et al., 1987;
Hiscock et al., 2001), nuclear factor-B,
Ap-1 (Rong and Baudry, 1996), DREAM
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Figure 5. REST expression inhibits M-current and increases excitability in small-diameter DRG neurons. DRG neurons were
infected with an adenoviral construct expressing GFP only (Ad) or REST and GFP (AdREST) and assessed functionally using wholecell patch clamp. In cultures infected with REST and GFP, both green (AdREST) and non-green (AdREST non-infected) cells were
tested. Only small-diameter neurons (18 –35 pF) responsive to the TRPV1 agonist capsaicin (1 M) were investigated. A, Wholecell voltage-clamp traces obtained by 500 ms voltage pulses from ⫺30 to ⫺60 mV as indicated by the voltage pulse protocol
(inset). Black trace represents steady-state basal current; red trace represents current in the presence of the specific M-channel
blocker XE991 (3 M). Dotted line indicates zero current. B, Whole-cell current-clamp traces in which voltage was adjusted to ⫺65
mV by current injection and 4 s square current pulses to different test currents were applied (inset). C, Bars show pooled current
density data determined from the experiments shown in A. Magnitude of M-current was calculated as the XE991-sensitive deactivation current when stepping from ⫺30 to ⫺60 mV and normalized to cell capacitance (IM density). Number of experiments is
indicated within bars [**p ⬍ 0.01 compared to Ad and AdRes⫹ (noninfected)]. D, Bars show mean resting membrane potentials
of GFP, REST, and non-infected neurons. Membrane potential was measured in current-clamp mode (0 pA) [**p ⬍ 0.01 compared
to Ad and AdRest (noninfected)]. E, Exemplary current-clamp experiment showing excitatory effect of 3 M XE991. Current
injections at 400 pA (inset) were applied to whole-cell current-clamped DRG neurons before and during XE991 application. No
voltage adjustment was performed.
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scription (Plaisance et al., 2005). Such a
model is consistent with our data in which
the ability of REST to repress KCNQ2 and
KCNQ3 appears to be dominant over the
ability of Sp1 to activate these genes and
suggests that interaction between REST
and Sp1 may be important for regulating
the expression of many neuronal-specific
genes. Consistent with such a hypothesis is the observation that, in addition
to KCNQ2 and KCNQ3, many RESTregulated genes are also known to be regulated by Sp1. For example, Chrm4 (Wood et
al., 1996), Nmdar1 (Bai et al., 1998), Gria2
(Myers et al., 1998), synatophysin (Lietz et
al., 2003), and Bsx (Park et al., 2007) genes
are all regulated by both REST and Sp1,
whereas regulation of the -opioid receptor
gene involves an interaction with REST and
the Sp1 family member Sp3 (Kim et al.,
2006).
Recently, much interest has been placed
on Kv7 channels as a potential target for analgesics in pain (Passmore et al., 2003; Linley
et al., 2008; Brown and Passmore, 2009;
Wickenden and McNaughton-Smith,
2009). Activators of Kv7 channels had an
analgesic effect in a hindpaw model of
chronic pain (Passmore et al., 2003), inhibited ectopic firing of axotomized sensory fibers (Roza and Lopez-Garcia, 2008), and
reduced behavior associated with visceral
pain (Hirano et al., 2007). Furthermore,
pharmacological inhibition of M-channels
at peripheral nerve terminals by acute injection of M-channel blocker XE991 produced
spontaneous pain (Linley et al., 2008; Liu et
al., 2010). Our data suggest that REST expression increases whereas Kv7.2 expression and M-current density decreases in
Figure 6. Inflammatory stimuli results in an increase in neuronal REST levels. A, B, Fluorescent images of DRG neurons cultured DRG neurons under chronic inflammain control conditions (top) or exposed to a mixture of inflammatory mediators (bottom) for 48 h. REST (A, red), Kv7.2 (B, red), and tory treatment. All these findings sugTRPV1 (green) levels were analyzed by anti-REST, anti-Kv7.2, and anti-TRPV1 antibodies and Alexa Fluor-555 (REST and Kv7.2) or gest that transcriptional downregulation
Alexa Fluor-488 (TRPV1) conjugated secondary antibodies. Scale bars, 10 m. C, Bars show the pixel intensity of TRPV1, REST, and of M-channel expression in nociceptive
Kv7.2 staining in TRPV1-positive neurons in control conditions (Con) and after exposure to inflammatory mediators (Inflam) pathways may result in painful phenotype
(mean ⫾ SEM; n ⱖ 12; *p ⬍ 0.05).
and contribute to chronic pain conditions. Moreover, peripheral axotomiza(downstream regulatory element antagonist modulator) (Matsution in a rat model for neuropathic pain resulted in changes in the
ura et al., 2002), and REST (Palm et al., 1998). One report has also
gene expression profile of DRGs (Xiao et al., 2002). Levels of
shown that Sp1 levels increase after seizure (Feng et al., 1999),
neither KCNQ nor REST genes were reported in this study, but
although another found no changes in levels of Sp1 (Rong and
two well known REST target genes, chromagranin A and SNAP25
Baudry, 1996). Given our findings, an increase in expression of
(synaptosomal-associated protein 25), showed reduced expresthe transcriptional REST would result in a decrease in KCNQ2
sion in axotomized DRGs (Xiao et al., 2002). Recently, expression
and KCNQ3 expression, resulting in an increase in the excitability
of REST was shown to be upregulated after neuropathic injury
of the affected neurons. REST represses gene expression by re(Uchida et al., 2010), thus it is tempting to speculate that the
cruiting protein complexes that modify the posttranslational
KCNQ–REST pathway discovered here may contribute to neuromarks within chromatin (Ooi and Wood, 2007). Thus, any
pathic pain pathophysiology.
changes induced on REST recruitment have the potential to
Here we identify two transcription factors, Sp1 and REST, that
be stably maintained even if REST expression is subsequently
are important for regulating expression of the potassium channel
reduced, providing a prospective mechanism for long-term
genes KCNQ2 and KCNQ3. Regulation of KCNQ2 and KCNQ3
changes in gene expression levels. In addition to repressing tranby these transcription factors may be important for long-term
scription by modifying chromatin, REST has also been shown to
changes in expression levels in response to epileptic seizure activinteract with Sp1 and inhibit the ability of Sp1 to enhance tranity and during chronic pain syndromes.
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